Pfizer, DL Medicine Launch Drug Discovery Collaboration
Pfizer will partner with NetVation DL Medicine (DL Medicine) on a two-year research collaboration intended to produce new chemical entities against pre-selected targets from multiple therapeutic areas, the Chinese biotech said today.The value of the collaboration was not disclosed, though Pfizer has taken an unspecified financial stake in DL Medicine, a newly-formed discovery-stage company focused on accelerating drug discovery by applying emerging technologies.DL Medicine investors include Anlo
Read more »